Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sticky platelet syndrome.

E F Mammen1

  • 1Wayne State University School of Medicine, Detroit, Michigan, USA.

Seminars in Thrombosis and Hemostasis
|November 5, 1999
PubMed
Summary
This summary is machine-generated.

Sticky Platelet Syndrome (SPS) causes hyperactive platelets, leading to dangerous blood clots. Low-dose aspirin effectively treats this inherited disorder, reducing clot risk and symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disseminated intravascular coagulation (DIC).

Clinical laboratory science : journal of the American Society for Medical Technology·2001
Same author

Oral contraceptive pills and hormonal replacement therapy and thromboembolic disease.

Hematology/oncology clinics of North America·2000
Same author

Low molecular weight heparins and heparin-induced thrombocytopenia.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2000
Same author

The effects of a low-dose monophasic preparation of levonorgestrel and ethinyl estradiol on coagulation and other hemostatic factors.

American journal of obstetrics and gynecology·1999
Same author

Clinical differentiation of low molecular weight heparins.

Seminars in thrombosis and hemostasis·1999
Same author

Antithrombin III and sepsis.

Intensive care medicine·1998
Same journal

Bridging the Gap in Laboratory Monitoring of Extended Half-Life Factor VIII and IX: Can Thrombin Generation Assays Overcome Assay Discrepancies?

Seminars in thrombosis and hemostasis·2026
Same journal

External Quality Assessment for Low Molecular Weight Heparin Monitoring in the Australasia/Asia-Pacific Region.

Seminars in thrombosis and hemostasis·2026
Same journal

Human evolution: between hemorrhage and thrombosis.

Seminars in thrombosis and hemostasis·2026
Same journal

Full- vs Reduced-Dose Direct Oral Anticoagulants for Extended Treatment of Cancer-Associated Thrombosis: A Multicenter Retrospective Cohort Study.

Seminars in thrombosis and hemostasis·2026
Same journal

Too Old for PESI?: Risk Stratification of Octogenarians with Pulmonary Embolism in the Emergency Department.

Seminars in thrombosis and hemostasis·2026
Same journal

Acute Management and Bleeding Outcomes in Pediatric Pulmonary Embolism: A Large Single-Center Retrospective Cohort Study.

Seminars in thrombosis and hemostasis·2026
See all related articles

Area of Science:

  • Hematology
  • Genetics
  • Cardiology

Background:

  • Sticky Platelet Syndrome (SPS) is an inherited platelet disorder.
  • It causes abnormal platelet aggregation, increasing thrombosis risk.
  • SPS is linked to arterial and venous thromboembolic events.

Purpose of the Study:

  • To describe the clinical presentation and characteristics of Sticky Platelet Syndrome.
  • To investigate the efficacy of low-dose aspirin in managing SPS.
  • To explore potential underlying mechanisms of platelet hyperreactivity in SPS.

Main Methods:

  • Review of clinical cases and laboratory findings in patients with SPS.
  • Platelet aggregation studies using adenosine diphosphate (ADP) and epinephrine.
  • Assessment of clinical outcomes and symptom amelioration with low-dose aspirin therapy.

Related Experiment Videos

Main Results:

  • SPS patients exhibit hyperaggregable platelets upon stimulation with ADP or epinephrine.
  • Clinical manifestations include recurrent arterial and venous thrombosis, often triggered by stress.
  • Low-dose aspirin (80-100 mg) effectively reduces symptoms and normalizes platelet hyperaggregability.

Conclusions:

  • Sticky Platelet Syndrome is a significant cause of unexplained vascular occlusions.
  • Low-dose aspirin is a beneficial treatment for managing SPS.
  • Further research into the molecular basis of platelet hyperreactivity in SPS is warranted.